PCOS Second Pregnancy: What the Recurrence Numbers Actually Show

This page is about a second pregnancy once it has already started — not about getting there. It sits inside the wider fertility coverage on this site, alongside two closely related questions: PCOS secondary infertility covers why conceiving again can be harder the second time, and PCOS after pregnancy notes, in a single line, that “none of the risk or metabolic information above resets between pregnancies.” This page is the data behind that sentence.

How Much Does a Prior Gestational Diabetes Pregnancy Raise the Odds of a Repeat?

A prior episode of gestational diabetes (GDM) raises the odds of a second one to roughly ten times the baseline. In a Kaiser Permanente Southern California cohort of 65,132 women with two consecutive singleton pregnancies, 41.3% of women with GDM in their first pregnancy had it again in their second, against 4.2% of women with no prior GDM (OR 13.2, 95% CI 12.0–14.6). Among a smaller group of 13,096 women tracked through a third pregnancy, having GDM in both prior pregnancies pushed the odds even higher, to an OR of 25.9 (95% CI 17.4–38.4) for a third episode. This is a general obstetric population, not a PCOS-specific one — race and ethnicity moved the risk further still, with the study finding higher recurrence among Hispanic and Asian/Pacific Islander women than white women in the same cohort.

None of this changes what standard care already looks for. The 2023 international guideline already recommends an oral glucose tolerance test before conception or at the first prenatal visit for anyone with PCOS, rather than waiting for the usual 24–28-week window — a documented prior GDM episode is exactly the history that recommendation exists to catch early, not a new decision your team needs to invent from scratch.

Does Having PCOS Specifically Raise That Recurrence Risk Further?

PCOS shows up disproportionately often in the group whose gestational diabetes comes back. A 2024 Italian study of 759 multiparous women tested with the 75-gram OGTT in two consecutive pregnancies split them into four groups: normal glucose tolerance in both pregnancies (n=493), GDM appearing for the first time in the second pregnancy (n=74), GDM in the first pregnancy only (n=92), and GDM in both pregnancies (n=100). PCOS prevalence climbed sharply across those groups — 1.6% (8/493), 2.7% (2/74), 10.9% (10/92), and 34.0% (34/100), respectively (p < 0.001). That comparison is descriptive, not an adjusted odds ratio isolating PCOS from the obesity and insulin resistance that often travel with it, but the gradient is hard to read any other way: a third of the women with GDM in both pregnancies had PCOS, against under 3% of the women whose glucose stayed normal both times.

What About Hypertensive Disorders — Pre-eclampsia and Gestational Hypertension?

A hypertensive pregnancy disorder recurs in roughly one in five subsequent pregnancies across the general population. An individual-patient-data meta-analysis pooling 22 studies and 99,415 women found a 20.7% recurrence rate (95% CI 20.4–20.9%) for any hypertensive disorder of pregnancy (HDP); a wider pooled analysis using published data from 64 studies and 152,213 women found a similar 18.1% (95% CI 17.9–18.3%). Broken down by what actually came back, recurrence took the shape of pre-eclampsia specifically in 13.8% of cases (95% CI 13.6–14.1%), gestational hypertension in 8.6% (95% CI 8.4–8.8%), and HELLP syndrome in 0.2% (95% CI 0.16–0.25%). None of this is PCOS-specific — no study identified for this page has measured HDP recurrence inside a PCOS-only population, despite PCOS itself roughly doubling the odds of a first hypertensive disorder — a figure covered in full on PCOS pregnancy risks.

Recurrence risk is not flat across everyone who had a hypertensive disorder once — it depends heavily on how severe that first episode was. A 2024 retrospective study of 519 women with a prior pre-eclampsia diagnosis across two Chinese tertiary hospitals found 153 of them, or 29.5%, developed pre-eclampsia again in their next pregnancy — notably higher than the general 20.7% HDP figure above, because this cohort specifically selected for a prior pre-eclampsia diagnosis rather than any hypertensive disorder. Two factors independently predicted that recurrence: a previous early-onset pre-eclampsia (before 34 weeks) carried an adjusted odds ratio of 4.22 (95% CI 2.50–7.13), and having chronic hypertension going into the current pregnancy carried an adjusted odds ratio of 1.86 (95% CI 1.09–3.18).

If a Hypertensive Disorder Comes Back, Is the Second Episode Worse or Milder?

The IPD meta-analysis above found that when a hypertensive disorder did recur, it was, on average, milder than the first time — lower maximum diastolic blood pressure, less proteinuria, less use of oral antihypertensive and anticonvulsant medication, fewer small-for-gestational-age babies, less prematurity, and fewer perinatal deaths compared with the index pregnancy. That is a genuinely reassuring finding for the roughly four out of five women in that dataset whose disorder did not return at all, and for the one in five whose did.

The Chinese cohort above complicates that reassurance in one respect: among the 519 women with a prior pre-eclampsia diagnosis, those who had a recurrence had 5.8 times the rate of preterm birth of those who did not (50.7% vs. 8.7%). Read together, both things are true: recurrence is less severe than the original episode was, and a pregnancy where it does recur still carries meaningfully higher preterm-birth risk than one where it does not. There is also a longer-range signal worth naming: normotensive women whose hypertensive disorder recurred were more likely to develop chronic hypertension after pregnancy than women whose disorder did not recur (OR 3.7, 95% CI 2.3–6.1) — a reason this is a conversation for your antenatal team and not only a pregnancy-by-pregnancy question.

Do PCOS Symptoms Themselves Change by the Time of a Second Pregnancy?

There is real evidence that the PCOS phenotype softens over time, but it is not evidence about pregnancy specifically. A retrospective longitudinal study of 254 women with PCOS, reassessed after an interval of 0.5 to 7 years, found that significantly more women had a regular cycle at their second visit, and that testosterone, androstenedione and DHEA-S had all fallen significantly, alongside a significant drop in fasting insulin and HOMA-IR. The study measured the effect of time passing — it did not track who had given birth in the interval, did not compare mothers with non-mothers, and did not isolate pregnancy as a variable at all. No study identified for this page has done that isolation. The honest answer is that PCOS is documented to soften with age on average, and whether a first pregnancy itself contributes anything beyond the years it took to have one is simply not known.

Does Weight Change Between Pregnancies Move These Numbers?

Weight gained between pregnancies is one of the stronger, more modifiable predictors of a repeat gestational diabetes episode — not a verdict on what happened in the interval. The Schwartz 2016 meta-analysis found women whose GDM recurred had gained 3.24 kg more, on average, between pregnancies than women whose GDM did not recur (P=.012), with a standardized effect size (SMD 0.8) notably larger than any other factor the same analysis measured, including age and pre-pregnancy BMI. The mechanism runs through the same insulin and androgen pathway covered for conception odds on the secondary-infertility page — it is a metabolic input the pancreas and ovaries respond to, not a report on effort or discipline between two pregnancies. It also runs in both directions: the same body of evidence that shows weight gained between pregnancies raising GDM recurrence odds provides no basis for assuming weight lost in the interval erases PCOS-driven risk entirely, only that it moves the same lever the other way.

Who This Recurrence Data Does Not Apply To

• If your first pregnancy had neither gestational diabetes nor a hypertensive disorder, none of the recurrence-specific numbers above are about you — PCOS is still an independent baseline risk factor for a first episode of either, covered with its own figures on pregnancy risks in PCOS, but recurrence math does not apply to a complication you have not had.
• If your first episode was mild gestational hypertension, not pre-eclampsia, the 29.5% figure from the Chinese cohort is not your number — that cohort selected specifically for a prior pre-eclampsia diagnosis, and the broader 18–21% figure is the more relevant one for gestational hypertension alone.
• If your metabolic markers have measurably improved since your first pregnancy — through treatment, time, or otherwise — the same predictors that raise recurrence risk when they move in one direction are the ones that would be expected to lower it when they move in the other; no study has quantified that specific improvement scenario, but the mechanism described above does not run one-way only.

None of the risk data above changes what to eat once a second pregnancy is confirmed — that is a separate question, covered on its own terms in what to eat in the first trimester with PCOS, rather than repeated here.

You may see PCOS written as polyendocrine metabolic ovarian syndrome (PMOS), after a 2026 global consensus of more than 50 organisations renamed it. Every figure above still applies under either name — only the label changed, and this article uses PCOS because that is still the term most readers search. None of the recurrence data above is PCOS-specific by design; where a PCOS-only figure exists, as with the Mirabelli 2024 GDM data, it is marked as such.